Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Suita, Japan
Department of Laboratory Medicine, Osaka University Graduate School of Medicine, Suita, Japan
Search for other papers by Toru Takano in
Google Scholar
PubMed
Prefecture and Kitaibaraki in Ibaraki Prefecture [ 3 , 4 ]. A common feature of these areas is that thyroid screening for children with ultrasonography (US) has been carried out by the local government. Some experts stated that the increasing incidence of
Search for other papers by Mohamed Abdouh in
Google Scholar
PubMed
Search for other papers by Roger Tabah in
Google Scholar
PubMed
Search for other papers by Vincenzo Arena in
Google Scholar
PubMed
Search for other papers by Manuel Arena in
Google Scholar
PubMed
Search for other papers by Zu-hua Gao in
Google Scholar
PubMed
Istituto Oncologico del Mediterraneo, Viagrande, Italy
Search for other papers by Aurelio Lorico in
Google Scholar
PubMed
Istituto Oncologico del Mediterraneo, Viagrande, Italy
Department of Surgery, McGill University, St. Mary Hospital, Montreal, Québec, Canada
Search for other papers by Goffredo Orazio Arena in
Google Scholar
PubMed
. There is a rise in the incidence of salivary gland cancers; this group accounted for 6.3% of all head and neck cancers in 1974–1976, as compared to 8.1% in 1998–1999 [ 1 ]. The propensity of the thyroid gland to form nodules is demonstrated by the
Search for other papers by Thea Riis in
Google Scholar
PubMed
Search for other papers by Steen Joop Bonnema in
Google Scholar
PubMed
Search for other papers by Thomas Heiberg Brix in
Google Scholar
PubMed
Search for other papers by Lars Folkestad in
Google Scholar
PubMed
consequently, a lower absolute risk of being diagnosed with cancer ( 30 ). We adjusted for this competing risk of death using the Fine and Gray competing risk regression model ( 28 ) and computed a cause-specific cumulative incidence function. This provides the
Search for other papers by Matthieu Bosset in
Google Scholar
PubMed
Search for other papers by Maxime Bonjour in
Google Scholar
PubMed
Search for other papers by Solène Castellnou in
Google Scholar
PubMed
Search for other papers by Zakia Hafdi-Nejjari in
Google Scholar
PubMed
Search for other papers by Claire Bournaud-Salinas in
Google Scholar
PubMed
Search for other papers by Myriam Decaussin-Petrucci in
Google Scholar
PubMed
Laboratoire Health Services and Performance Research (EA 7425 HESPER), Université Claude Bernard Lyon 1, Villeurbanne, France
Search for other papers by Jean Christophe Lifante in
Google Scholar
PubMed
Search for other papers by Agnès Perrin in
Google Scholar
PubMed
Search for other papers by Jean-Louis Peix in
Google Scholar
PubMed
CarMeN Laboratory, Université Claude-Bernard Lyon 1, Inserm U1060, INRA U1397, INSA Lyon, IMBL, Villeurbanne, France
Search for other papers by Philippe Moulin in
Google Scholar
PubMed
Search for other papers by Geneviève Sassolas in
Google Scholar
PubMed
Search for other papers by Michel Pugeat in
Google Scholar
PubMed
Registre des Cancers Thyroïdiens du Département du Rhône, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron, France
Laboratoire Health Services and Performance Research (EA 7425 HESPER), Université Claude Bernard Lyon 1, Villeurbanne, France
Search for other papers by Françoise Borson-Chazot in
Google Scholar
PubMed
Introduction Thyroid cancer is the most common endocrine malignancy, and its incidence globally has increased over the last 30 years [ 1 , 2 ]. Papillary thyroid cancer (PTC) represents more than 90% of all thyroid cancer cases and is the
Search for other papers by Patrick W. Owens in
Google Scholar
PubMed
Cancer Genetics Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom
Search for other papers by Terri P. McVeigh in
Google Scholar
PubMed
Search for other papers by Eoin J. Fahey in
Google Scholar
PubMed
Search for other papers by Marcia Bell in
Google Scholar
PubMed
Search for other papers by Denis S. Quill in
Google Scholar
PubMed
Search for other papers by Michael J. Kerin in
Google Scholar
PubMed
Search for other papers by Aoife J. Lowery in
Google Scholar
PubMed
Introduction Thyroid cancer (TC) is the most common endocrine malignancy, accounting for 1% of all cancers, with an incidence of 162 cases per year in Ireland [ 1 ]. The National Cancer Registry Ireland reports increasing incidence of TC from
Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, São Paulo, Brazil
Search for other papers by Carolina C.P.S. Janovsky in
Google Scholar
PubMed
Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, São Paulo, Brazil
Search for other papers by Rui M.B. Maciel in
Google Scholar
PubMed
Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, São Paulo, Brazil
Search for other papers by Cleber P. Camacho in
Google Scholar
PubMed
Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, São Paulo, Brazil
Search for other papers by Rosalia P. Padovani in
Google Scholar
PubMed
Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, São Paulo, Brazil
Search for other papers by Claudia C. Nakabashi in
Google Scholar
PubMed
Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, São Paulo, Brazil
Search for other papers by Ji H. Yang in
Google Scholar
PubMed
Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, São Paulo, Brazil
Search for other papers by Eduardo Z. Malouf in
Google Scholar
PubMed
Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, São Paulo, Brazil
Search for other papers by Elza S. Ikejiri in
Google Scholar
PubMed
Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, São Paulo, Brazil
Search for other papers by M. Conceição O.C. Mamone in
Google Scholar
PubMed
Search for other papers by Jairo Wagner in
Google Scholar
PubMed
Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, São Paulo, Brazil
Search for other papers by Danielle M. Andreoni in
Google Scholar
PubMed
Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, São Paulo, Brazil
Search for other papers by Rosa Paula M. Biscolla in
Google Scholar
PubMed
Introduction The incidence of differentiated thyroid cancer is rising significantly, but it is not accompanied by a proportional increase in mortality [ 1 , 2 , 3 , 4 ]. This phenomenon is mainly due to the early diagnosis of small tumors
Search for other papers by Hirotoshi Nakamura in
Google Scholar
PubMed
Search for other papers by Akane Ide in
Google Scholar
PubMed
Search for other papers by Takumi Kudo in
Google Scholar
PubMed
Search for other papers by Eijun Nishihara in
Google Scholar
PubMed
Search for other papers by Mitsuru Ito in
Google Scholar
PubMed
Search for other papers by Akira Miyauchi in
Google Scholar
PubMed
upper cutoff of TRAb is 1.9 IU/l. Results AG Patients For a recent 5-year period, we had 25 patients (all of them were female) who developed AG. The incidence of AG is 0.24% (25/10,410 patients). Sixteen of the 25 AG patients (64%) were
Department of Otorhinolaryngology-Head and Neck Surgery, Chungnam National University Sejong Hospital, Sejong, Republic of Korea
Search for other papers by Ho-Ryun Won in
Google Scholar
PubMed
Search for other papers by Min Gyu Kim in
Google Scholar
PubMed
Search for other papers by Min Soo Kim in
Google Scholar
PubMed
Department of Otolaryngology-Head and Neck Surgery, Chungnam National University Hospital, Daejeon, Republic of Korea
Search for other papers by Jae Won Chang in
Google Scholar
PubMed
Department of Otolaryngology-Head and Neck Surgery, Chungnam National University Hospital, Daejeon, Republic of Korea
Search for other papers by Bon Seok Koo in
Google Scholar
PubMed
Introduction Thyroid cancer is the most common cancer among tumors of endocrine origin. According to the Global Cancer Statistics in 2020, approximately 586,202 people are diagnosed with thyroid cancer each year, and it ranks 11th in incidence
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Valentina Cirello in
Google Scholar
PubMed
Search for other papers by Marina Lugaresi in
Google Scholar
PubMed
Search for other papers by Claudia Moneta in
Google Scholar
PubMed
Center for Interdisciplinary Research on Medicines (C.I.R.M.), University of Liege (ULiège), CHU (B35), Liege, Belgium
Search for other papers by Patrice Dufour in
Google Scholar
PubMed
Department of Biotechnology and Translational Medicine, University of Milan, Milan, Italy
Search for other papers by Alessandro Manzo in
Google Scholar
PubMed
Search for other papers by Erika Carbone in
Google Scholar
PubMed
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Carla Colombo in
Google Scholar
PubMed
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Laura Fugazzola in
Google Scholar
PubMed
Center for Interdisciplinary Research on Medicines (C.I.R.M.), University of Liege (ULiège), CHU (B35), Liege, Belgium
Search for other papers by Corinne Charlier in
Google Scholar
PubMed
Center for Interdisciplinary Research on Medicines (C.I.R.M.), University of Liege (ULiège), CHU (B35), Liege, Belgium
Search for other papers by Catherine Pirard in
Google Scholar
PubMed
Introduction Thyroid cancer (TC) is the most frequent endocrine tumor with age-standardized incidence rates of approximately 10.1 per 100,000 women and 3.1 per 100,000 men in 2020 (F:M = 3:1 on average), and with a low mortality rate (0.5 per
Search for other papers by Dulani Kottahachchi in
Google Scholar
PubMed
Department of Medicine, Monash University, Melbourne, VIC, Australia
Search for other papers by Duncan J. Topliss in
Google Scholar
PubMed
diseases have been reported to be IgG4-related. Modified from Umehara et al. [ 7 ] with permission. Sparse data exist on the epidemiology of IgG4-RD. Asian data predominates, with 1 Japanese study estimating the annual incidence of IgG4-RD to be 0